Couttas, T. A.; Boost, C.; Pahlisch, F.; Sykorova, E. B.; Leweke, J. E.; Koethe, D.; Endepols, H.; Rohleder, C.; Leweke, F. M.: Simultaneous assessment of serum levels and pharmacologic Eeffects of cannabinoids on endocannabinoids and N-acylethanolamines by liquid chromatography-tandem mass spectrometry. Cannabis and Cannabinoid Research (accepted)

Trempler, I.; Binder, E.; Reuter, M.; Plieger, T.; Standke, I.; Mecklenbrauck, F.; Meinert, S.; Forstner, A. J.; Nothen, M. M.; Rietschel, M. et al.; Stürmer, S.; Dannlowski, U.; Tittgemeyer, M.; Lencer, R.; Fink, G. R.; Schubotz, R. I.: Effects of DRD2/ANKK1 and COMT Val158Met polymorphisms on stabilization against and adaptation to unexpected events. Cerebral Cortex (accepted)

Kierdorf, F.; Zimmer, P.; Joisten, N.; Kiesl, D.; Winker, M.; Rigoux, L.; Elter, T.: L-kynurenine as a prognostic marker for early mortality in patients with acute myeloid leukemia. Leukemia and Lymphoma (accepted)

Aponte, E. A.; Yao, Y.; Raman, S.; Frässle, S.; Heinzle, J.; Penny, W. D.; Stephan, K. E.: An introduction to thermodynamic integration and application to dynamic causal models. Cognitive Neurodynamics 16 (1), pp. 1 - 15 (2022)

Endepols, H.; Anglada-Huguet, M.; Mandelkow, E.; Schmidt, Y.; Krapf, P.; Zlatopolskiy, B. D.; Neumaier, B.; Drzezga, A.: Assessment of the in vivo relationship between cerebral hypometabolism, Tau deposition, TSPO expression, and synaptic density in a tauopathy mouse model: a multi-tracer PET study. Molecular Neurobiology 59 (6), pp. 3402 - 3413 (2022)

Endepols, H.; Zlatopolskiy, B. D.; Zischler, J.; Alavinejad, N.; Apetz, N.; Vus, S.; Drzezga, A.; Neumaier, B.: Imaging of cerebral tryptophan metabolism using 7-[18F]FTrp-PET in a unilateral Parkinsonian rat model. NeuroImage 247, 118842 (2022)

Engelhard, C. A.; Huang, C.; Khani, S.; Kasparek, P.; Prochazka, J.; Rozman, J.; Reguera, D. P.; Sedlacek, R.; Kornfeld, J.-W.: Comprehensive transcriptional profiling and mouse phenotyping reveals dispensable role for adipose tissue selective long noncoding RNA Gm15551. Non-coding RNA 8 (3), 32 (2022)

Frässle, S.; Stephan, K. E.: Test-retest reliability of regression dynamic causal modeling. Network Neuroscience 6 (1), pp. 135 - 160 (2022)

Hanssen, R.; Thanarajah, S. E.; Tittgemeyer, M.; Brüning, J. C.: Obesity - A Matter of Motivation? Experimental and Clinical Endocrinology & Diabetes 130 (5), pp. 290 - 295 (2022)

Jais, A.; Brüning, J. C.: Arcuate nucleus-dependent regulation of metabolism - pathways to obesity and diabetes mellitus. Endocrine Reviews 43 (2), pp. 314 - 328 (2022)

Kasper, L.; Engel, M.; Heinzle, J.; Mueller-Schrader, M.; Graedel, N. N.; Reber, J.; Schmid, T.; Barmet, C.; Wilm, B. J.; Stephan, K. E. et al.; Pruessmann, K. P.: Advances in Spiral fMRI: A High-resolution Study with Single-shot Acquisition. NeuroImage 246, 118738 (2022)

Lippert, R. N.; Brüning, J. C.: Maternal metabolic programming of the developing central nervous system – unified pathways to metabolic and psychiatric disorders. Biological Psychiatry 91 (10), pp. 898 - 906 (2022)

Loehrer, P. A.; Weber, I.; Oehrn, C. R.; Nettersheim, F. S.; Dafsari, H. S.; Knake, S.; Tittgemeyer, M.; Timmermann, L.; Belke, M.: Microstructural alterations predict impaired bimanual control in Parkinson's disease. Brain Communications 4 (3), fcac137 (2022)

Matsushita, M.; Awazawa, M.; Kobayashi, N.; Ikushima, Y. M.; Soeda, K.; Tamura-Nakano, M.; Muratani, M.; Kobayashi, K.; Bluher, M.; Brüning, J. C. et al.; Ueki, K.: An antisense transcript transcribed from Irs2 locus contributes to the pathogenesis of hepatic steatosis in insulin resistance. Cell Chemical Biology 29 (4), pp. 680 - 689.e6 (2022)

Meron, E.; Thaysen, M.; Angeli, S.; Antebi, A.; Barzilai, N.; Baur, J. A.; Bekker-Jensen, S.; Birkisdottir, M.; Bischof, E.; Brüning, J. C. et al.; Brunet, A.; Buchwalter, A.; Cabreiro, F.; Cai, S.; Chen, B. H.; Ermolaeva, M.; Ewald, C. Y.; Ferrucci, L.; Florian, M. C.; Fortney, K.; Freund, A.; Georgievskaya, A.; Gladyshev, V. N.; Glass, D.; Golato, T.; Gorbunova, V.; Hoejimakers, J.; Houtkooper, R. H.; Jager, S.; Jaksch, F.; Janssens, G.; Jensen, M. B.; Kaeberlein, M.; Karsenty, G.; de Keizer, P.; Kennedy, B.; Kirkland, J. L.; Kjaer, M.; Kroemer, G.; Lee, K.-F.; Lemaitre, J.-M.; Liaskos, D.; Longo, V. D.; Lu, Y.-X.; MacArthur, M. R.; Maier, A. B.; Manakanatas, C.; Mitchell, S. J.; Moskalev, A.; Niedernhofer, L.; Ozerov, I.; Partridge, L.; Passegue, E.; Petr, M. A.; Peyer, J.; Radenkovic, D.; Rando, T. A.; Rattan, S.; Riedel, C. G.; Rudolph, L.; Ai, R.; Serrano, M.; Schumacher, B.; Sinclair, D. A.; Smith, R.; Suh, Y.; Taub, P.; Trapp, A.; Trendelenburg, A.-U.; Valenzano, D. R.; Verburgh, K.; Verdin, E.; Vijg, J.; Westendorp, R. G.J.; Zonari, A.; Bakula, D.; Zhavoronkov, A.; Scheibye-Knudsen, M.: Meeting Report: Aging Research and Drug Discovery. Aging 14 (2), pp. 530 - 543 (2022)

Ophey, A.; Krohm, F.; Kalbe, E.; Greuel, A.; Drzezga, A.; Tittgemeyer, M.; Timmermann, L.; Jessen, F.; Eggers, C.; Maier, F.: Neural correlates and predictors of subjective cognitive decline in patients with Parkinson's disease. Neurological Sciences 43 (5), pp. 3153 - 3163 (2022)

Pelzer, E. A.; Stürmer, S.; Feis, D.-L.; Melzer, C.; Schwartz, F.; Scharge, M.; Eggers, C.; Tittgemeyer, M.; Timmermann, L.: Clustering of Parkinson subtypes reveals strong influence of DRD2 polymorphism and gender. Scientific Reports 22 (1), 6038 (2022)

Ramírez, S.; Haddad-Tóvolli, R.; Radosevic, M.; Toledo, M.; Pané, A.; Alcolea, D.; Ribas, V.; Milà-Guasch, M.; Pozo, M.; Obri, A. et al.; Eyre, E.; Gómez-Valadés, A. G.; Chivite, I.; Van Eeckhout, T.; Zalachoras, I.; Altirriba, J.; Bauder, C.; Imbernón, M.; Garrabou, G.; Garcia-Ruiz, C.; Nogueiras, R.; Soto, D.; Gasull, X.; Sandi, C.; Brüning, J. C.; Fortea, J.; Jiménez, A.; Fernández-Checa, J. C.; Claret, M.: Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders. Cell Metabolism 34 (2), pp. 269 - 284.e9 (2022)

Richter, N.; David, L.-S.; Grothe, M. J.; Teipel, S.; Dietlein, M.; Tittgemeyer, M.; Neumaier, B.; Fink, G. R.; Onur, O. A.; Kukolja, J.: Age and anterior basal forebrain volume predict the cholinergic deficit in patients with mild cognitive impairment due to Alzheimer's disease. Journal of Alzheimer's Disease: JAD 86 (1), pp. 425 - 440 (2022)

Walter, N.; Bertram, J.; Drewes, B.; Bahutsky, V.; Timmer, M.; Schütz, M. B.; Krämer, F.; Neumaier, F.; Endepols, H.; Neumaier, B. et al.; Zlatopolskiy, B. D.: Convenient PET-tracer production via SuFEx 18F-fluorination of nanomolar precursor amounts. European Journal of Medicinal Chemistry 237, 114383 (2022)

Weber, J.-P. D.; Spiro, J. E.; Scheffler, M.; Wolf, J.; Nogova, L.; Tittgemeyer, M.; Maintz, D.; Laue, H.; Persigehl, T.: Reproducibility of dynamic contrast enhanced MRI derived transfer coefficient Ktrans in lung cancer. PLoS One 17 (3), e0265056 (2022)

Weber, L. A.; Tomiello, S.; Schöbi, D.; Wellstein, K. V.; Müller, D.; Iglesias, S.; Stephan, K. E.: Auditory mismatch responses are differentially sensitive to changes in muscarinic acetylcholine versus dopamine receptor function. eLife 11, e74835 (2022)

Werr, L.; Plenker, D.; Dammert, M. A.; Lorenz, C.; Bragelmann, J.; Tumbrink, H. L.; Klein, S.; Schmitt, A.; Buttner, R.; Persigehl, T. et al.; Shokat, K. M.; Wunderlich, F. T.; Schram, A. M.; Peifer, M.; Sos, M. L.; Reinhardt, H. C.; Thomas, R. K.: CD74-NRG1 fusions are oncogenic in vivo and induce therapeutically tractable ERBB2:ERBB3 heterodimerization. Molecular Cancer Therapeutics 21 (5), pp. 821 - 830 (2022)

Zumbansen, A.; Kneifel, H.; Lazzouni, L.; Ophey, A.; Black, S. E.; Chen, J. L.; Edwards, D.; Funck, T.; Hartmann, A. E.; Heiss, W.-D. et al.; Hildesheim, F.; Lanthier, S.; Lesperance, P.; Mochizuki, G.; Paquette, C.; Rochon, E.; Rubi-Fessen, I.; Valles, J.; Wortmann-Jutt, S.; Thiel, A.: Differential effects of speech and language therapy and rTMS in chronic versus subacute post-stroke aphasia: Results of the NORTHSTAR-CA trial. Neurorehabilitation and Neural Repair 36 (4-5), pp. 306 - 316 (2022)